More Fractures In Women on Takeda Pharmaceutical Co. Ltd. (Jobs) Diabetes Drug Says FDA
WASHINGTON, March 9 (Reuters) - Women taking Takeda Pharmaceutical Co. Ltd.'s. (4502.T: Quote, NEWS , Research) pioglitazone drug for diabetes had more reports of fractures in clinical trials than those taking a placebo or another drug, the company and U.S. health officials said in a notice to physicians released on Friday.